Company News
Dr. Reddy’s Laboratories launches Omeprazole and sodium bicarbonate capsules in the US market
Dr. Reddy’s Laboratories launches Omeprazole and sodium bicarbonate capsules in the US market
![]()
By eHealth Network - 19 July 2016
Dr Reddys launches Zegerid generic in US market
Dr. Reddys Laboratories Ltd, an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives, announced on July 18 that it has launched Omeprazole and sodium bicarbonate capsules, 20 mg/1100 mg and 40 mg/1100 mg, a therapeutic equivalent generic version of Zegerid® (omeprazole/sodium bicarbonate) capsules in the United States (US) market, having been approved by the US Food & Drug Administration (USFDA).
Key Takeaways
- The Zegerid® brand and generic had US sales of approximately $306.7 million MAT for the most recent 12 months ending in May 2016 according to IMS Health.
- Dr. Reddys Omeprazole and sodium bicarbonate capsules 20 mg/1100 mg and 40 mg/1100 mg are available in bottle count size of 30.
- Zegerid® is a registered trademark of Santarus, Inc. a wholly owned subsidiary of Salix Pharmaceuticals, Inc.
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
